115 related articles for article (PubMed ID: 12736088)
1. D-cycloserine for the treatment of ataxia in spinocerebellar degeneration.
Ogawa M; Shigeto H; Yamamoto T; Oya Y; Wada K; Nishikawa T; Kawai M
J Neurol Sci; 2003 Jun; 210(1-2):53-6. PubMed ID: 12736088
[TBL] [Abstract][Full Text] [Related]
2. The stereo-specific effect of D-serine ethylester and the D-cycloserine in ataxic mutant mice.
Saigoh K; Matsui K; Takahashi K; Nishikawa T; Wada K
Brain Res; 1998 Oct; 808(1):42-7. PubMed ID: 9795125
[TBL] [Abstract][Full Text] [Related]
3. Placebo-controlled trial of D-cycloserine added to conventional neuroleptics, olanzapine, or risperidone in schizophrenia.
Heresco-Levy U; Ermilov M; Shimoni J; Shapira B; Silipo G; Javitt DC
Am J Psychiatry; 2002 Mar; 159(3):480-2. PubMed ID: 11870017
[TBL] [Abstract][Full Text] [Related]
4. A placebo-controlled trial of D-cycloserine added to conventional neuroleptics in patients with schizophrenia.
Goff DC; Tsai G; Levitt J; Amico E; Manoach D; Schoenfeld DA; Hayden DL; McCarley R; Coyle JT
Arch Gen Psychiatry; 1999 Jan; 56(1):21-7. PubMed ID: 9892252
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of cycloserine in the treatment of Alzheimer's disease.
Fakouhi TD; Jhee SS; Sramek JJ; Benes C; Schwartz P; Hantsburger G; Herting R; Swabb EA; Cutler NR
J Geriatr Psychiatry Neurol; 1995 Oct; 8(4):226-30. PubMed ID: 8561836
[TBL] [Abstract][Full Text] [Related]
6. Pilot-controlled trial of D-cycloserine for the treatment of post-traumatic stress disorder.
Heresco-Levy U; Kremer I; Javitt DC; Goichman R; Reshef A; Blanaru M; Cohen T
Int J Neuropsychopharmacol; 2002 Dec; 5(4):301-7. PubMed ID: 12466030
[TBL] [Abstract][Full Text] [Related]
7. Improved cognition in Alzheimer's disease with short-term D-cycloserine treatment.
Tsai GE; Falk WE; Gunther J; Coyle JT
Am J Psychiatry; 1999 Mar; 156(3):467-9. PubMed ID: 10080566
[TBL] [Abstract][Full Text] [Related]
8. D-cycloserine adjuvant therapy to molindone in the treatment of schizophrenia.
Rosse RB; Fay-McCarthy M; Kendrick K; Davis RE; Deutsch SI
Clin Neuropharmacol; 1996 Oct; 19(5):444-50. PubMed ID: 8889288
[TBL] [Abstract][Full Text] [Related]
9. The Cognitive and Negative Symptoms in Schizophrenia Trial (CONSIST): the efficacy of glutamatergic agents for negative symptoms and cognitive impairments.
Buchanan RW; Javitt DC; Marder SR; Schooler NR; Gold JM; McMahon RP; Heresco-Levy U; Carpenter WT
Am J Psychiatry; 2007 Oct; 164(10):1593-602. PubMed ID: 17898352
[TBL] [Abstract][Full Text] [Related]
10. Effect of rovatirelin in patients with cerebellar ataxia: two randomised double-blind placebo-controlled phase 3 trials.
Nishizawa M; Onodera O; Hirakawa A; Shimizu Y; Yamada M;
J Neurol Neurosurg Psychiatry; 2020 Mar; 91(3):254-262. PubMed ID: 31937586
[TBL] [Abstract][Full Text] [Related]
11. D-cycloserine added to clozapine for patients with schizophrenia.
Goff DC; Tsai G; Manoach DS; Flood J; Darby DG; Coyle JT
Am J Psychiatry; 1996 Dec; 153(12):1628-30. PubMed ID: 8942463
[TBL] [Abstract][Full Text] [Related]
12. Difference in the effects of tandospirone on ataxia in various types of spinocerebellar degeneration: an open-label study.
Takei A; Hamada S; Homma S; Hamada K; Tashiro K; Hamada T
Cerebellum; 2010 Dec; 9(4):567-70. PubMed ID: 20809107
[TBL] [Abstract][Full Text] [Related]
13. High-dose piracetam is effective on cerebellar ataxia in patient with cerebellar cortical atrophy.
Vural M; Ozekmekçi S; Apaydin H; Altinel A
Mov Disord; 2003 Apr; 18(4):457-9. PubMed ID: 12671958
[TBL] [Abstract][Full Text] [Related]
14. D-cycloserine treatment of Alzheimer disease.
Randolph C; Roberts JW; Tierney MC; Bravi D; Mouradian MM; Chase TN
Alzheimer Dis Assoc Disord; 1994; 8(3):198-205. PubMed ID: 7986489
[TBL] [Abstract][Full Text] [Related]
15. Augmentation of exposure therapy with D-cycloserine for social anxiety disorder.
Hofmann SG; Meuret AE; Smits JA; Simon NM; Pollack MH; Eisenmenger K; Shiekh M; Otto MW
Arch Gen Psychiatry; 2006 Mar; 63(3):298-304. PubMed ID: 16520435
[TBL] [Abstract][Full Text] [Related]
16. Dose-finding trial of D-cycloserine added to neuroleptics for negative symptoms in schizophrenia.
Goff DC; Tsai G; Manoach DS; Coyle JT
Am J Psychiatry; 1995 Aug; 152(8):1213-5. PubMed ID: 7625475
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological treatments of cerebellar ataxia.
Ogawa M
Cerebellum; 2004; 3(2):107-11. PubMed ID: 15233578
[TBL] [Abstract][Full Text] [Related]
18. A pilot study of D-cycloserine in subjects with autistic disorder.
Posey DJ; Kem DL; Swiezy NB; Sweeten TL; Wiegand RE; McDougle CJ
Am J Psychiatry; 2004 Nov; 161(11):2115-7. PubMed ID: 15514414
[TBL] [Abstract][Full Text] [Related]
19. Augmentation of behavior therapy with D-cycloserine for obsessive-compulsive disorder.
Wilhelm S; Buhlmann U; Tolin DF; Meunier SA; Pearlson GD; Reese HE; Cannistraro P; Jenike MA; Rauch SL
Am J Psychiatry; 2008 Mar; 165(3):335-41; quiz 409. PubMed ID: 18245177
[TBL] [Abstract][Full Text] [Related]
20. A trial of d-cycloserine to treat the social deficit in older adolescents and young adults with autism spectrum disorders.
Urbano M; Okwara L; Manser P; Hartmann K; Deutsch SI
J Neuropsychiatry Clin Neurosci; 2015; 27(2):133-8. PubMed ID: 25923852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
